HARROW, INC. (HROW)
$37.77-$0.77 (-2.00%) Today
Latest HROW Insider Trades
Amir Shojaei - OfficerOpen-market sale
Amir Shojaei - Officer
Mark L. Baum - Officer
Andrew R. Boll - OfficerHarrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 11,250 | $450K |
| Grant or award | 3 | 15,744 | |
| Option exercise | 2 | 22,500 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
21 Form 4 filings on record, the earliest from Apr 7, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Amir Shojaei - Officer | Option exercise | Common Stock | 11,250 | $35.96 | $405K | |
| Amir Shojaei - Officer | Open-market sale | Common Stock | 11,250 | $40.00 | $450K | |
| Amir Shojaei - Officer | Option exercise | Stock Option (Right to Buy) | 11,250 | $35.96 | $405K | |
| Perry J. Sternberg - Director | Grant or award | RSU | 5,248 | $0.00 | - | |
| Lauren P. Silvernail - Director | Grant or award | RSU | 5,248 | $0.00 | - | |
| Adrienne L. Graves - Director | Grant or award | RSU | 5,248 | $0.00 | - | |
| Adrienne L. Graves - Director | Open-market purchase | Common Stock | 1,000 | $31.07 | $31K | |
| Lauren P. Silvernail - Director | Open-market purchase | Common Stock | 1,000 | $31.00 | $31K | |
| Amir Shojaei - Officer | Grant or award | Restricted Stock Units | 10,000 | $0.00 | - | |
| Mark L. Baum - Officer | Open-market purchase | Common Stock | 10,000 | $30.20 | $302K | |
| Andrew R. Boll - Officer | Open-market purchase | Common Stock | 3,500 | $29.90 | $105K | |
| Opaleye Management Inc. - 10% Owner | Open-market sale | Common Stock, par value $0.001 per share | 4,263 | $39.67 | $169K | |
| Opaleye Management Inc. - 10% Owner | Open-market sale | Common Stock, par value $0.001 per share | 59,000 | $39.15 | $2.31M | |
| Opaleye Management Inc. - 10% Owner | Open-market sale | Common Stock, par value $0.001 per share | 1,309 | $39.15 | $51K | |
| Opaleye Management Inc. - 10% Owner | Open-market sale | Common Stock, par value $0.001 per share | 134,000 | $39.67 | $5.32M | |
| Opaleye Management Inc. - 10% Owner | Open-market sale | Common Stock, par value $0.001 per share | 5,000 | $54.18 | $271K | |
| Patrick William Sullivan - Officer | Grant or award | RSU | 25,000 | $0.00 | - | |
| Patrick William Sullivan - Officer | Grant or award | RSU | 15,000 | $0.00 | - | |
| Opaleye Management Inc. - 10% Owner | Open-market sale | Common Stock, par value $0.001 per share | 20,000 | $53.35 | $1.07M | |
| Andrew R. Boll - Officer | Option exercise | Common Stock | 60,000 | $3.95 | $237K | |
| Andrew R. Boll - Officer | Tax withholding / forfeiture | Common Stock | 26,665 | $47.06 | $1.25M | |
| Andrew R. Boll - Officer | Option exercise | Stock Option (Right to Buy) | 60,000 | $0.00 | - | |
| Mark L. Baum - Officer | Option exercise | Common Stock | 180,000 | $3.95 | $711K | |
| Mark L. Baum - Officer | Tax withholding / forfeiture | Common Stock | 79,994 | $47.06 | $3.76M | |
| Mark L. Baum - Officer | Option exercise | Stock Option (Right to Buy) | 180,000 | $0.00 | - | |
| Randall E. Pollard - Officer | Grant or award | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Mark L. Baum - Officer | Option exercise | Common stock | 600,000 | $7.87 | $4.72M | |
| Mark L. Baum - Officer | Tax withholding / forfeiture | Common stock | 313,338 | $37.08 | $11.62M | |
| Mark L. Baum - Officer | Option exercise | Stock Option (Right to Buy) | 600,000 | $0.00 | - | |
| Mark L. Baum - Officer | Grant or award | RSU | 889,500 | $0.00 | - | |
| Andrew R. Boll - Officer | Grant or award | RSU | 405,750 | $0.00 | - | |
| Lauren P. Silvernail - Director | Grant or award | RSU | 7,339 | $0.00 | - | |
| Mark L. Baum - Officer | Option exercise | Common Stock | 762,300 | $0.00 | - | |
| Mark L. Baum - Officer | Tax withholding / forfeiture | Common Stock | 300,363 | $23.09 | $6.94M | |
| Mark L. Baum - Officer | Option exercise | Performance Stock Unit | 762,300 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| AMIR SHOJAEI | CHIEF SCIENTIFIC OFFICER | 11,250 | $450K | View on EDGAR |
HARROW, INC. (HROW) had 4 insider filings in the last 90 days, with the most recent on 2026-08-17. The full record for HROW runs to 21 Form 4 filings, the earliest from 2025-04-07. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of HROW were filed in the last 90 days. 4 purchases are on record for this company.
1 insider sale of HROW was filed in the last 90 days, totaling $450K.
This page tracks HROW Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add HROW to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
